Literature DB >> 30969388

Palliative Care and Symptom Burden in the Last Year of Life: A Population-Based Study of Patients with Gastrointestinal Cancer.

Shaila J Merchant1,2, Susan B Brogly3, Christopher M Booth4, Craig Goldie5, Sulaiman Nanji3,6, Sunil V Patel3,6, Katherine Lajkosz7, Nancy N Baxter8,9,10.   

Abstract

INTRODUCTION: The symptom profile in cancer patients and the association between palliative care (PC) and symptoms has not been studied in the general population. We addressed these gaps in gastrointestinal (GI) cancer patients in the final year of life.
METHODS: Patients dying of esophageal, gastric, colon, and anorectal cancers during 2003-2015 were identified. Symptom scores were recorded in the year before death using the Edmonton Symptom Assessment System (ESAS), which includes scores from 0 to 10 in nine domains. Symptom severity was categorized as none-mild (≤ 3) or moderate-severe (≥ 4-10). Adjusted associations between outpatient PC and moderate-severe ESAS scores were determined, and the effect of PC initiation on ESAS scores was estimated.
RESULTS: The cohort included 11,242 patients who died (esophageal [17%], gastric [20%], colon [38%], and anorectal [26%] cancers). Fifty percent experienced moderate-severe scores in tiredness, lack of well-being, and lack of appetite earlier (weeks 18 to 12 before death), whereas 50% experienced moderate-severe scores in drowsiness, pain, and shortness of breath later (weeks 5 to 2 before death) in the disease course. Outpatient PC was associated with an increased likelihood of moderate-severe scores in all domains, with the highest score in pain (odds ratio [OR] 1.86, 95% confidence interval [CI] 1.68-2.05). In PC-naïve patients with moderate-severe scores, initiation of outpatient PC was associated with a 1- to 3-point decrease in subsequent scores, with the greatest reductions in pain (OR - 1.91, 95% CI - 2.11 to - 1.70) and nausea (OR - 3.01, 95% CI - 3.31 to - 2.71).
CONCLUSION: GI cancer patients experience high symptom burden in the final year of life. Outpatient PC initiation is associated with a decrease in symptoms.

Entities:  

Year:  2019        PMID: 30969388     DOI: 10.1245/s10434-019-07320-z

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  6 in total

1.  Use of Palliative Interventions at End of Life for Advanced Gastrointestinal Cancer.

Authors:  Vivi W Chen; Jorge I Portuondo; Zara Cooper; Nader N Massarweh
Journal:  Ann Surg Oncol       Date:  2022-08-10       Impact factor: 4.339

2.  Artificial neural networks for simultaneously predicting the risk of multiple co-occurring symptoms among patients with cancer.

Authors:  Wenhui Xuyi; Hsien Seow; Rinku Sutradhar
Journal:  Cancer Med       Date:  2020-12-22       Impact factor: 4.452

3.  Real‑world challenge for clinicians treating advanced gastroesophageal adenocarcinoma (Review).

Authors:  Mark A Baxter; Russell D Petty; Daniel Swinson; Peter S Hall; Shane O'Hanlon
Journal:  Int J Oncol       Date:  2021-03-24       Impact factor: 5.650

4.  The Variations in Care and Real-world Outcomes in Individuals With Rectal Cancer: Protocol for the Ontario Rectal Cancer Cohort.

Authors:  Sunil Patel; Chad McClintock; Christopher Booth; Shaila Merchant; Carl Heneghan; Clare Bankhead
Journal:  JMIR Res Protoc       Date:  2022-08-05

5.  Physical and psychological symptoms and signs in dying digestive tract cancer patients: the East Asian collaborative cross-cultural Study to Elucidate the Dying process (EASED).

Authors:  Jinyoung Shin; Sun Hyun Kim; Sang-Yeon Suh; Shao-Yi Cheng; Ping-Jen Chen; Takashi Yamaguchi; Tatsuya Morita; Satoru Tsuneto; Masanori Mori
Journal:  Support Care Cancer       Date:  2020-11-10       Impact factor: 3.359

6.  Impact of palliative therapies in metastatic esophageal cancer patients not receiving chemotherapy.

Authors:  Sungjin Kim; Timothy P DiPeri; Michelle Guan; Veronica R Placencio-Hickok; Haesoo Kim; Jar-Yee Liu; Andrew Hendifar; Samuel J Klempner; Ryan Nipp; Alexandra Gangi; Miguel Burch; Kevin Waters; May Cho; Joseph Chao; Katelyn Atkins; Mitchell Kamrava; Richard Tuli; Jun Gong
Journal:  World J Gastrointest Surg       Date:  2020-09-27
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.